In the continuing raging controversy over mandatory vaccination, Health Minister Mückstein now presents a new Corona drug as “hope” for the unvaccinated.
Soon the antibody-drug “Evusheld” for protection against COVID-19 will be available in Austria. Health Minister Wolfgang Mückstein announced a news release Wednesday. “For people who cannot be vaccinated for medical reasons or for whom vaccination does not work, Evusheld offers an alternative to the Corona vaccine,” he said.
He said he is glad to offer a protection option to this vulnerable group. His department recently signed the relevant contract with AstraZeneca, he said.
“With the antibody preparation AZD7442 – Evusheld – developed by AstraZeneca, a drug is now available that offers these groups of people effective protection against COVID-19,” Mückstein emphasizes. “The drugs represent an effective additional measure for at-risk patients – let’s use them!”
In Austria, Evusheld will be used as a preventive measure, i.e., when patients have not yet come into contact with the virus, and will become available in Austria during March.
The antibody combination was developed primarily for high-risk patients who either have an inadequate immune response to a vaccine or cannot be vaccinated with an available vaccine – and thus have an increased risk of a severe course.
In particular, these include people with blood cancers or other cancers undergoing active chemotherapy, dialysis patients, or people taking immunosuppressive drugs after organ transplantation or due to diseases such as multiple sclerosis and rheumatoid arthritis.
- source: heute.at/picture: pixabay.com
This post has already been read 154 times!